جست‌وجوی استاد و پژوهشگر

• Skeletal Muscle Growth
• Ribosome Biogenesis
• Exercise Physiology
• +۴ مورد دیگر

Gustavo Nader, Ph.D., is a Professor of Kinesiology at The Pennsylvania State University's College of Health and Human Development, where he holds the Dorothy Foehr Huck and J. Loyd Huck Endowed Chair in Molecular, Cellular and Integrative Physiology. His research laboratory at 101 Noll Lab focuses on molecular mechanisms of skeletal muscle adaptation, employing human, animal, and cellular models to investigate ribosome biogenesis, transcriptional regulation, and muscle growth control in contexts ranging from exercise hypertrophy to cancer cachexia. Dr. Nader's research examines fundamental processes including: Ribosome biogenesis and its role in muscle growth regulation Epigenetic control of RNA Polymerase I activity Molecular pathways in mechanical overload-induced hypertrophy Tumor-induced muscle wasting mechanisms Biomimicry approaches inspired by hibernator physiology His work spans exercise physiology, cancer biology, and environmental stress responses. Analysis of his 15 most recent publications (2015-2025) reveals predominant themes in muscle hypertrophy mechanisms, cancer cachexia pathophysiology, ribosomal function analysis, and environmental stress impacts on muscle. His work consistently integrates molecular techniques with physiological models across species. Notable scientific recognitions include: Dorothy Foehr Huck and J. Loyd Huck Chair appointment (2024) Huck Institutes Leadership Fellowship (2025-2026) Dr. Nader leads an active research team investigating muscle plasticity, with current projects funded through the Huck Institutes of the Life Sciences. He collaborates extensively through Penn State's Integrative and Biomedical Physiology graduate program and Center for Cellular Dynamics.

Mirko Trajkovskiمشاهده پروفایل

استاد

• Metabolic Diseases
• Obesity
• Insulin Resistance
• +۵ مورد دیگر

Professor Mirko Trajkovski leads the Laboratory of Metabolic Diseases at the Faculty of Medicine, University of Geneva. He completed his PhD at the International Max Planck School in Dresden (2005), followed by postdoctoral research at ETH Zurich, before establishing his lab at University College London (2012) and moving to Geneva (2013). His work focuses on adipose tissue plasticity , gut microbiota , and their roles in obesity , diabetes , and insulin resistance . Swiss National Science Foundation Professor (2014) ERC Starting Grant (2014) & Consolidator Grant (2019) Dr Walter Seipp Prize & Carl Gustav Carus Prize (2005) His lab investigates fat browning mechanisms , microbiota-host communication , and multi-tissue metabolic regulation using in vivo , in vitro , and human cohort approaches. Recent publications emphasize microbiome-based therapies , temperature effects on metabolism , and gut-bone-adipose crosstalk . Current advisees include PhD student Silas Kieser, with past members like Jing Xue, Salvatore Fabbiano, and Claire Chevalier contributing to immuno-metabolism and microbial engineering projects.

Bo Liمشاهده پروفایل

استاد

• Neuroscience
• Neural circuits
• Synaptic plasticity
• +۱۲ مورد دیگر

Bo Li is the Robert Lourie Professor of Neuroscience at Cold Spring Harbor Laboratory (CSHL) in the School of Biological Sciences. His research focuses on the neural circuits underlying cognitive function and dysfunction related to anxiety, depression, schizophrenia, and autism, with particular emphasis on synaptic mechanisms and rodent behavioral models. He earned his Ph.D. in Neuroscience from the University of British Columbia in 2003. Education: Ph.D., Neuroscience, University of British Columbia (2003) M.Sc., Psychology, Chinese Academy of Sciences (1997) B.Sc., Medicine, Jining Medical College (1992) Li's lab integrates in vitro and in vivo electrophysiology, imaging, molecular and genetic techniques, optogenetics, and chemogenetics to probe fear and reward circuits in rodent brains. His work examines how these circuits contribute to adaptive and maladaptive behaviors, with significant implications for understanding mental disorders. Recent publications highlight his exploration of the vitamin B6 pathway in cancer, opioid neuropeptide dynamics in motivation, and area postrema neurons in brain-body interactions. His research also addresses salience assignment through striatal-amygdala circuits and dietary choice regulation via neurotensin neurons in the extended amygdala. Scientific awards include: HFSP Research Grant awards 2015 NARSAD Independent Investigator grant WSBS Teaching Award 2015 Students in his lab include Sara Boyle, Mingzhe Liu, and Danielle van de Lisdonk. His work has been supported by NIH BRAIN Initiative grants and involves collaborations across multiple CSHL laboratories.

• Skeletal Muscle Physiology
• Ribosome Biogenesis
• Transcriptional Regulation
• +۴ مورد دیگر

Gustavo Alberto Nader is a Professor of Kinesiology at The Pennsylvania State University , holding the Dorothy Foher and J. Lloyd Huck Chair in Molecular, Cellular and Integrative Physiology. His research focuses on skeletal muscle growth control , ribosome biogenesis , and transcriptional/epigenetic regulation in health and disease contexts. Affiliated with the Huck Institutes of the Life Sciences and College of Health and Human Development Principal Investigator on NIH-funded projects examining ribosomal control of muscle mass Research Interests span molecular mechanisms of muscle adaptation to exercise, cancer cachexia, chronic disease impacts on muscle, and cross-species Wnt signaling regulation by CO₂ levels. Key methodologies include human/animal/cell models, ribosomal analysis, and epigenetic profiling. Publication Trends show sustained focus on: Ribosome biogenesis in muscle hypertrophy (2012–2025) Cancer-induced muscle wasting mechanisms (2015–2024) CO₂/Wnt pathway interactions (2015–2019) Exercise-induced transcriptional responses (2001–2016) Scientific Awards include the Huck Chair, while his Grants & Collaborations involve NIH-funded studies on transcriptional/epigenetic mechanisms (2019–2026) with cross-disciplinary teams in physiology, oncology, and respiratory medicine.

Ziad Mallatمشاهده پروفایل

استاد

• Cardiovascular biology
• immune mechanisms of cardiovascular disease
• atherosclerosis
• +۳ مورد دیگر

Professor Ziad Mallat is a distinguished Professor of Cardiovascular Medicine at the University of Cambridge, where he serves as the BHF Professor of Cardiovascular Medicine since 2010. He is affiliated with the Victor Phillip Dahdaleh Heart & Lung Research Institute and is a Principal Investigator in the Cardiovascular and Respiratory Medicine section of the Department of Medicine. Elected as a Fellow of the Academy of Medical Sciences (FMedSci) in 2020, Professor Mallat has established himself as a leading figure in cardiovascular immunology research. Professor Mallat received his MD and degree in Cardiovascular Disease from University of Paris VI, and his PhD from University of Paris VII. He was appointed Director of Research at Inserm, France, in 2007. His academic journey has positioned him at the forefront of cardiovascular research, with particular expertise in immune mechanisms of cardiovascular disease. Professor Mallat's research focuses on the immune mechanisms leading to cardiovascular inflammation in atherosclerosis, post-ischaemic injury (such as myocardial infarction), and aortic aneurysm and dissection. His laboratory develops novel immuno-modulatory and vaccination-based strategies to promote protective immune responses, aiming to radically change the management and treatment of these common and serious cardiovascular diseases. His approach combines basic science research, pre-clinical experimentation in animals, and translation clinical investigation in patients. Analysis of Professor Mallat's recent publications reveals a strong focus on the intersection of immunology and cardiovascular disease, particularly investigating regulatory T cells, B cell responses in atherosclerosis, and immune-modulatory therapies. His work spans from fundamental mechanisms to clinical translation, with several studies examining therapeutic approaches like low-dose interleukin-2 for cardiovascular inflammation. Fellow of the Academy of Medical Sciences (FMedSci) Co-Editor of Atherosclerosis journal Editorial Board member of Circulation Research and JCI Insight Professor Mallat has published over 250 papers in peer-reviewed journals, with landmark contributions including identifying prominent roles for specific pathogenic and regulatory immune pathways in atherosclerosis and post-ischaemic remodeling. His basic research activities are complemented by proof-of-concept clinical trials using immune-modulatory therapies in patients with coronary artery disease. He maintains active collaborations with the British Heart Foundation and is involved in the Cambridge BHF Centre of Research Excellence.

• Innovation Studies
• Sustainability Transitions
• Economic Geography
• +۴ مورد دیگر

Teis Hansen is a Professor of Innovation and Entrepreneurship at the Department of Food and Resource Economics , University of Copenhagen, with a side-position at SINTEF 's Department of Technology Management in Norway. His academic background includes a PhD in Economic Geography (2012) and an MSc in Regional and Urban Planning Studies (2008, LSE). His research spans innovation studies, sustainability transitions, and economic geography , focusing on spatial innovation dynamics, transformative policy, green urban development, foundational economy, and technology transfer between developed and emerging economies. Empirical work covers bioeconomy, energy-intensive industries, maritime transport, plastics, and energy systems. Recent collaborations include international partnerships in Norway, Sweden, and Denmark. His 112 research outputs include 63 journal articles, 9 book chapters, and policy-relevant reports. Key publications address climate change mitigation frameworks, carbon capture feasibility, and circular bioeconomy transitions .

Reilly T. Enosمشاهده پروفایل

استادیار

• Obesity
• Metabolic Disease
• Sex Differences in Metabolism
• +۹ مورد دیگر

Reilly T. Enos, PhD, is an Assistant Professor in the Department of Pathology, Microbiology & Immunology at the University of South Carolina School of Medicine. His research focuses on the molecular mechanisms of sex differences in obesity, particularly metabolic and inflammatory processes influenced by sex steroids. The Enos Lab employs rodent models and advanced metabolic phenotyping to investigate menopause-related metabolic dysfunction and complementary therapies. PhD, Exercise Science (Applied Physiology), University of South Carolina, 2013 Post-Doctoral, Complementary and Alternative Medicine in Cancer and Obesity, University of South Carolina School of Medicine, 2017 MS, Exercise Physiology, Baylor University, 2009 BS, Dietetics, University of Northern Colorado, 2010 BA, Spanish & Physical Education, College of Wooster, 2007 Dr. Enos’s research spans immunometabolism, obesity, cancer cachexia, and gut microbiota. His work explores how dietary components (e.g., quercetin, emodin), hormonal status (especially estrogen), and immune modulation (e.g., miR-155, macrophages) influence metabolic and oncological outcomes. He investigates sex-specific responses to high-fat diets, inflammation, and therapeutic interventions using transgenic and diet-induced mouse models. His recent publications highlight trends in metabolic physiology, inflammation, and cancer, often examining the interplay between adipose tissue, immune cells, and hormonal regulation. Key themes include the impact of vivarium conditions on reproducibility, the role of microRNAs in tumorigenesis, and the safety and efficacy of natural compounds. Dr. Enos has not been awarded any listed scientific prizes or fellowships in the provided texts. He advises a research team focused on metabolic and inflammatory disease models, frequently collaborating with researchers such as Erin A. Murphy and Kandy T. Velázquez. His lab receives funding for studies on obesity, cancer, and complementary medicine, though specific grants are not detailed. The lab is equipped for metabolic phenotyping and rodent model studies. The Enos Lab is dedicated to understanding sex-specific metabolic regulation and developing targeted therapies for obesity and cancer-related metabolic disorders, with a focus on translational relevance and experimental rigor.

Bumsoo Ahnمشاهده پروفایل

استادیار

• Mitochondria
• Aging
• Muscle
• +۱۲ مورد دیگر

Bumsoo Ahn, PhD, is an Assistant Professor in the Department of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. He is also affiliated with the Wake Forest Institute for Regenerative Medicine, Center for Redox Biology and Medicine, Sticht Center for Healthy Aging and Alzheimer’s Prevention, Cardiovascular Sciences Center, Comprehensive Cancer Center, Center for Precision Medicine, and the Center for Vaccines at the Extremes of Aging. His educational background includes a BS from Yonsei University (2004), an MS from the University of North Carolina at Chapel Hill (2011), and a PhD from the University of Florida (2015). Dr. Ahn's research focuses on the mechanisms of muscle aging and wasting, particularly sarcopenia and cancer cachexia. His work emphasizes mitochondrial redox biology, oxidative stress, and the role of reactive oxygen species in muscle dysfunction. He employs transgenic mouse models to investigate causal relationships and test potential interventions, including unacylated ghrelin. His research spans molecular, cellular, and physiological levels, aiming to extend active and functional lifespans. His recent publications highlight investigations into mitochondrial hydrogen peroxide scavenging, SERCA activity restoration, neuronal SOD1 expression, and pharmacological protection against diaphragm dysfunction. These studies reflect a strong interdisciplinary focus on redox biology, muscle physiology, aging, and translational therapeutics. Scientific Awards: No awards listed in the provided text. Dr. Ahn contributes to graduate education through the Molecular Medicine and Translational Science PhD program and the Integrative Physiology and Pharmacology PhD program. His laboratory operates at the intersection of aging, regenerative medicine, and redox biology, engaging in collaborative research with multiple centers. While specific grants are not mentioned, his affiliations suggest involvement in federally and institutionally funded research initiatives focused on healthy aging and disease mitigation. The Ahn Lab investigates mitochondrial redox biology and muscle contractile properties in the context of aging and chronic diseases, utilizing animal models to identify therapeutic strategies for preserving muscle function.

Karl-Heinz Wagnerمشاهده پروفایل

استاد

• Oxidative stress and DNA stability
• Molecular nutrition and phytochemicals
• Dietary antioxidants and aging
• +۵ مورد دیگر

Karl-Heinz Wagner is Full Professor of Nutrition and Food Quality at the University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences. He directs an experimental research group investigating how lifestyle factors—diet, specific food components, phytochemicals, physical activity and bioactive non-food compounds—modulate oxidative stress and DNA stability in humans, with emphasis on aging and sarcopenia. He initiated the university-wide “Active Ageing” research platform and coordinates EU projects such as SHIFT2HEALTH. Education & Affiliations: University of Vienna, Faculty of Life Sciences, Department of Nutritional Sciences – Professor and Chair of Nutrition and Food Quality Principal investigator of the Emerging Field “Oxidative Stress and DNA Stability” Head of the “Active Ageing” research platform activeageing.univie.ac.at Research Focus: Prof. Wagner’s group applies state-of-the-art biochemical and molecular techniques to quantify antioxidant compounds, ROS-induced DNA and chromosomal damage, DNA repair capacity and transcriptional regulation of antioxidant defenses. Human intervention trials, cross-sectional cohorts and in-vitro models are used to examine: Impact of plant-based vs. animal-based diets on multimorbidity risk Nitrate-rich beetroot juice effects on microbiome, vascular function and oxidative stress Bilirubin biology and metabolic health in Gilbert’s syndrome High-protein nutrition and resistance training on DNA damage and muscle quality in older adults Microbiota-derived metabolites that enhance CD8 T-cell antitumor immunity after exercise Publication Trends 2023-2025: Recent output demonstrates a strategic shift toward multi-omics integration (metabolomics, lipidomics, proteomics) to dissect diet–microbiome–immune crosstalk and to identify predictive biomarkers of healthy ageing. Papers consistently appear in top-tier journals (Cell, Lancet Healthy Longev, Redox Biol, Mol Nutr Food Res) and embrace large multinational cohorts, randomized controlled trials and mechanistic animal/cellular work. Funding & Networks: Research is mainly funded by the Austrian Science Fund (FWF), National Bank, European Commission (Horizon 2020, Horizon Europe), EU Cross-Border Co-operation and the University of Vienna. A dense national and international partner network ensures continuous biomarker development and knowledge transfer. Student Training & Citizen Science: Prof. Wagner actively involves MSc/PhD students and post-docs in externally funded projects and advertises internships via ERASMUS+. Study participant recruitment portals for projects like SHIFT2HEALTH, NUTRIAGING and bilirubin clinical studies are maintained to engage the public and foster translational impact.

Natalia Imad Khalafمشاهده پروفایل

استادیار

• Pancreatic Cancer
• Gastroenterology
• Epidemiology
• +۳ مورد دیگر

Natalia Imad Khalaf, MD, MPH, FACP is an Assistant Professor in the Department of Medicine at Baylor College of Medicine with dual appointments as Clinical Investigator in the Clinical Effectiveness and Population Health Program and Core Faculty in the Health Policy, Quality & Informatics Program at the Center for Innovations in Quality, Effectiveness and Safety (IQuESt) at Michael E. DeBakey VA Medical Center. Her academic trajectory spans clinical gastroenterology, epidemiology, and health services research with focus on cancer outcomes. Her educational foundation includes: BA in Biological Sciences from Rice University (2007) MD from Baylor College of Medicine (2011) Internal Medicine Residency and Chief Medical Residency at Baylor College of Medicine (2014-2015) Gastroenterology & Hepatology Fellowship at Brigham and Women's Hospital (2018) MPH in Epidemiology from Harvard T.H. Chan School of Public Health (2018) Dr. Khalaf's research program centers on pancreatic cancer epidemiology, with emphasis on early detection biomarkers (particularly new-onset diabetes), metabolic risk factors, and healthcare system interventions. Her work integrates clinical gastroenterology with population health methodologies to address diagnostic delays, racial disparities in treatment, and implementation of evidence-based guidelines in gastrointestinal cancers. She actively develops risk prediction tools using health informatics and deep learning approaches. Analysis of her recent publications reveals a concentrated focus on pancreatic cancer pathophysiology and outcomes, with significant contributions to understanding pre-diagnostic metabolic changes, emergency presentation consequences, and diabetes-cancer linkages. Her colorectal cancer work examines screening adherence barriers and medication risk associations, while quality improvement research targets guideline implementation for gastric intestinal metaplasia. Her scientific recognition includes: AGA Academy of Educators Elected Member (2018) Bob Parsons Inaugural Fellow in Pancreatic Cancer Research (2017-2018) American Gastroenterological Association Early Career Investigator Recognition (2017) Soma Weiss Award for Clinical Teaching Excellence (2017) Dean of Medical Education Outstanding Resident Teacher Award (2013) Phi Beta Kappa Honor Society (2007) Dr. Khalaf directs multiple federally funded research initiatives including: VA Career Development Award: Health Informatics Approaches to Improve Early Diagnosis of Pancreatic Cancer ($1.09M, 2022-2026) National Academy of Sciences: Clinical Quality Measures for Gastrointestinal Cancers (2022-2027) Gordon and Betty Moore Foundation: Implementing Digital Quality Measures (2024-2025) American Pancreatic Association Young Investigator Grant (2019-2021) She operates within the IQuESt research ecosystem at the Michael E. DeBakey VA, leveraging the Clinical Effectiveness and Population Health Program infrastructure for her work on cancer diagnostic excellence, veteran health outcomes, and implementation science projects targeting gastrointestinal cancer care pathways.

John H. Stewart, IVمشاهده پروفایل

استاد

• Surgical Oncology
• Cancer Immunotherapy
• Clinical Trials
• +۵ مورد دیگر

John H. Stewart, IV serves as Chair of the Department of Surgery and Associate Dean of Oncology Programs at Morehouse School of Medicine, where he is a board-certified surgeon by the American Board of Surgery specializing in Surgical Oncology. His educational trajectory includes: BS in Zoology (Honors) from Louisiana Tech University MD from Howard University College of Medicine MBA from Wake Forest University General Surgery residencies at Temple University and Vanderbilt University Fellowship in Tumor Immunotherapy & Surgical Oncology at the National Institutes of Health Dr. Stewart's research program bridges Surgical Oncology, Cancer Immunotherapy, and Healthcare Disparities through innovative work in developmental oncoimmunotherapeutics and AI-driven healthcare delivery systems. He critically examines healthcare finance, policy, and operations to optimize cancer therapy access for underserved populations, with emphasis on structural barriers in treatment delivery. His publication record shows evolving focus from cytoreductive surgery techniques (2009-2012) toward contemporary immunometabolic reprogramming (2022-2023), tumor microenvironment dynamics, and bias analysis in colorectal cancer management. Recent work explores obesity-leukemia connections and cervical cancer immunology. Accolades include the 2023 Howard University Distinguished Alumni Award, University of Illinois Presidential Scholar (2018-2022), NCI Cancer Clinical Investigator Leadership Award (2013-2015), and consistent recognition in Best Doctors in America and US News Top Doctors listings. As academic administrator, Dr. Stewart directs surgical oncology programs while advancing health equity initiatives. His NCI award reflects substantial clinical investigation leadership, though specific grant details and student mentorship aren't documented in source materials. Based at Grady Memorial Hospital in Atlanta, his work integrates clinical practice, administrative leadership, and health disparities research to transform cancer care in marginalized communities through surgical innovation and policy reform.

Min Liمشاهده پروفایل

استاد

• GI Cancers
• Pancreatic Cancer
• Brain Tumor
• +۷ مورد دیگر

Min Li, PhD, is a Professor at the University of Oklahoma Health Sciences Center, holding multiple leadership roles including George Lynn Cross Research Professor, Virginia Kerley Cade Endowed Chair in Cancer Treatment, Assistant Dean for International Research Collaboration (College of Medicine), Vice Chair for Research (Department of Medicine), and Associate Director for Global Oncology (Stephenson Cancer Center). As Co-Leader of the Cancer Biology Program at Stephenson Cancer Center, President of the American Pancreatic Association, and Editor-in-Chief of Cancer Letters , Dr. Li is a foremost expert in pancreatic cancer pathogenesis. Education : BS (Shandong University, 1994), MS (Chinese Academy of Medical Science, 1997), PhD (Emory University, 2002) Dr. Li's research focuses on pancreatic cancer mechanisms, particularly the role of zinc transporter ZIP4, microRNA functions, cancer metabolism, and genomic sequencing. Their lab pioneered ZIP4's identification as a key oncogenic driver and developed shRNA-based therapies. With over 120 publications and NIH R01/R21 grants, Dr. Li mentors postdocs, students, and residents globally. Scientific Leadership : President of American Pancreatic Association Editorial Roles : Editor-in-Chief of Cancer Letters Endowments : George Lynn Cross Research Professor; Virginia Kerley Cade Endowed Chair Dr. Li's work combines basic science with clinical translation, serving as a member of NIH study sections and editorial boards across prestigious journals.

Helen Nobleمشاهده پروفایل

استاد

• Chronic Kidney Disease
• Palliative Care
• Qualitative Research Methods
• +۳ مورد دیگر

Helen Noble is a Professor of Nursing and Director of Postgraduate Research at the School of Nursing and Midwifery, Queen’s University Belfast. She leads international research in nephrology, palliative care, and arts-based interventions for kidney patients. Her roles include supervising PhD candidates, designing postgraduate training programs, and advocating for patient-centered care. She is a Fellow of the Higher Education Authority and has received accolades such as the Walls Bursary and Donna Lamping Award. Her research focuses on improving care for patients with chronic kidney disease, end-stage renal disease, and palliative needs. Notable initiatives include the UK Renal Arts Group, which uses creative arts to enhance patient well-being, and the Compassionate Mindful Resilience (CMR) program for kidney patients. She has secured funding from NIHR, Marie Curie, and other bodies. Teaching responsibilities include modules like Renal Nursing and Renal Replacement Therapies. She serves as an external examiner for nursing programs at City University London and University of Hertfordshire. Her grants and projects span caregiver support, palliative care partnerships, and mindfulness interventions in healthcare. Awards include the RCN Impact Award 2022 for her mindfulness program for PhD students. Her work is cited in international guidelines and disseminated through conferences, media, and collaborations with global organizations like the EDTNA/ERCA Research Board.

Loreena Hillمشاهده پروفایل

عضو هیئت علمی

• Heart Failure Management
• Palliative Care
• Cardiology
• +۳ مورد دیگر

Loreena Hill is an Honorary Professor at the School of Nursing and Midwifery, Queen's University Belfast (QUB). She holds a PhD in Nursing from Ulster University and has held roles including Lecturer (Teaching & Research) at QUB since 2018 and Adjunct Assistant Professor at MBRU (2020–2022). Her research focuses on Heart Failure (HF), particularly advanced HF symptoms and implanted devices like ICDs. She leads the European PASSION-HF project developing e-health tools for HF self-management and contributes to regionally funded initiatives. She has published in high-impact journals and authored a position statement on palliative care integration in HF management by the European Society of Cardiology's Heart Failure Association. Teaching: Coordinates modules in Applied Pharmacology for Nursing Practice and Prescribing in Practice, and contributes to specialist cardiology courses. Education: BSc Nursing (University of Ulster, 1991), MSc Nursing (QUB, 2006), PhD Nursing (Ulster University, 2015). Affiliations: Registered Nurse, NMC pin 86J0136N; member of the European Society of Cardiology committees (2024–2026). Research interests include HF self-management technologies, palliative care integration, and nursing education innovations. Her projects span care home HF education (Delphi studies) and quality-of-life optimization through digital interventions. Awards include the BHF Career Development Fellowship (2022) and STAR Scheme Performance Awards (2021/22). Advising & Grants: External examiner for Trinity College Dublin's Specialist Nursing program, and a PhD external examiner. Active in international conferences and peer review. Leads interdisciplinary teams across Europe and Asia in HF research and education. Labs/Teams: Collaborates with Mitchell, Brown Wilson, and Thompson on HF care home initiatives, and with global experts in machine learning for HF outcomes.

Michaela Noreikمشاهده پروفایل

استاد

• Obesity Research
• Geriatric Nutrition
• Dietetics
• +۳ مورد دیگر

Prof. Dr. Michaela Noreik serves as Professor in the Department of Nutritional Science at Niederrhein University of Applied Sciences, Mönchengladbach, where she teaches Interdisciplinary Casework, Planetary Health Diet, and Special Seminar in Nutrition Research. She directs the Laboratory for Nutritional Status and maintains active consultation hours for student engagement. Her educational foundation includes a Dr. rer. medic. in nutritional therapy evaluation from Universität zu Köln (2009-2012) and dual degrees in Oecotrophology (Fachhochschule Münster) and Nutrition and Dietetics (Fachhochschule Nimwegen, NL) completed between 2004-2008. Noreik's research centers on obesity interventions, geriatric nutrition, and sustainable dietary systems. She leads projects including OWL (Online Weight Loss programmes), CReDDI (dietary intervention metabolism studies), and SwapSHOP (digital grocery interventions). Her work bridges clinical practice with academic rigor, emphasizing evidence-based approaches to nutritional assessment and therapy standardization. Recent publications (2013-2021) reveal strong focus on digital health interventions for weight management, dietary approaches to type 2 diabetes, and nutritional implications in neurodegenerative conditions. Her methodology frequently employs randomized controlled trials and systematic reviews, with growing emphasis on planetary health frameworks and sustainable food systems. Her scientific recognition includes: 2019 Award of Excellence for Consistent Outstanding Performance (Oxford University) Noreik has secured significant third-party funding for clinical studies in obesity and oncology during her Oxford tenure. Current student projects involve developing nutrition assessment databases and implementing mobee®360 digital platforms. She actively supervises interdisciplinary casework modules with healthcare disciplines. She established the Laboratory for Nutritional Status at Niederrhein University and previously built nutrition teams at St. Marien-Hospital Köln. Her international collaborations include Hogeschool van Arnhem en Nijmegen and Umeå University for planetary health initiatives, reflecting her commitment to transnational research networks.